Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 9
Submit an article Journal homepage
209
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Early-onset Neovascular Inflammatory Vitreoretinopathy Due to Two de Novo CAPN5 Mutations in Chinese Patients: A Case Series

Feng-Jie XiaDepartment of Ophthalmology, Xinhua Hospital, Affiliated to Medicine School of Shanghai Jiaotong University, Shanghai, ChinaView further author information
, PhD,
Jiao LyuDepartment of Ophthalmology, Xinhua Hospital, Affiliated to Medicine School of Shanghai Jiaotong University, Shanghai, ChinaView further author information
, PhD,
Xiang ZhangDepartment of Ophthalmology, Xinhua Hospital, Affiliated to Medicine School of Shanghai Jiaotong University, Shanghai, ChinaView further author information
, MM,
Ping FeiDepartment of Ophthalmology, Xinhua Hospital, Affiliated to Medicine School of Shanghai Jiaotong University, Shanghai, ChinaORCID Iconhttps://orcid.org/0000-0001-7276-4630View further author information
, PhDORCID Icon &
Pei-Quan ZhaoDepartment of Ophthalmology, Xinhua Hospital, Affiliated to Medicine School of Shanghai Jiaotong University, Shanghai, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5092-9550View further author information
, MD, PhDORCID Icon
Pages 1777-1784 | Received 12 Nov 2021, Accepted 01 Aug 2022, Published online: 11 Nov 2022

References

  • Bennett SR, Folk JC, Kimura AE, Russell SR, Stone EM, Raphtis EM. Autosomal dominant neovascular inflammatory vitreoretinopathy. Ophthalmology. 1990;97(9):1125–1135. doi:10.1016/S0161-6420(90)32447-8.
  • Stone EM, Kimura AE, Folk JC, et al. Genetic linkage of autosomal dominant neovascular inflammatory vitreoretinopathy to chromosome 11q13. Hum Mol Genet. 1992;1(9):685–689. doi:10.1093/hmg/1.9.685.
  • Randazzo Nm Mbbch B, Shanks MEP, Clouston PPF, MacLaren RMCDF. Two novel CAPN5 variants associated with mild and severe autosomal dominant neovascular inflammatory vitreoretinopathy phenotypes. Ocul Immunol Inflamm. 2019;27(5):693–698. doi:10.1080/09273948.2017.1370651.
  • Dear N, Matena K, Vingron M, Boehm T. A new subfamily of vertebrate calpains lacking a calmodulin-like domain: implications for calpain regulation and evolution. Genomics. 1997;45(1):175–184. doi:10.1006/geno.1997.4870.
  • Mahajan VB, Skeie JM, Bassuk AG, et al. Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration. PLoS Genet. 2012;8(10):e1003001. doi:10.1371/journal.pgen.1003001.
  • Wert KJ, Bassuk AG, Wu WH, et al. CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model. Hum Mol Genet. 2015;24(16):4584–4598. doi:10.1093/hmg/ddv189.
  • Velez G, Bassuk AG, Schaefer KA, et al. A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay. Cold Spring Harb Mol Case Stud. 2018;4(3):a002519. doi:10.1101/mcs.a002519.
  • O’Keefe G, Hanif AM, Mahajan VB, Jain N. Early onset neovascular inflammatory vitreoretinopathy due to a de novo CAPN5 mutation: report of a case. Ocul Immunol Inflamm. 2019;27(5):706–708. doi:10.1080/09273948.2019.1582783.
  • Cham A, Bansal M, Banda HK, et al. Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy. Clin Ophthalmol. 2016;10:1187–1197. doi:10.2147/OPTH.S103324.
  • Tlucek PS, Folk JC, Orien JA, Stone EM, Mahajan VB. Inhibition of neovascularization but not fibrosis with the fluocinolone acetonide implant in autosomal dominant neovascular inflammatory vitreoretinopathy. Arch Ophthalmol. 2012;130(11):1395–1401. doi:10.1001/archophthalmol.2012.1971.
  • Ou Z, Zhao P, Zhang Q, Jin H. FLEXIBLE POLYPROPYLENE IRIS RETRACTORS MADE BY CAUTERY THERMOPLASTICITY: an instant intraoperative solution for small pupil vitrectomy. Retina (Philadelphia, Pa). 2018;38(11):2272–2274. doi:10.1097/IAE.0000000000002247.
  • Rowell HA, Bassuk AG, Mahajan VB. Monozygotic twins with CAPN5 autosomal dominant neovascular inflammatory vitreoretinopathy. Clin Ophthalmol. 2012;6:2037–2044.
  • Mahajan VB, Lin JH. Lymphocyte infiltration in CAPN5 autosomal dominant neovascular inflammatory vitreoretinopathy. Clin Ophthalmol. 2013;7:1339–1345. doi:10.2147/OPTH.S46450.
  • Bassuk AG, Yeh S, Wu S, et al. Structural modeling of a novel CAPN5 mutation that causes uveitis and neovascular retinal detachment. PloS one. 2015;10(4):e0122352. doi:10.1371/journal.pone.0122352.
  • Wang Y, Li H, Zang S, et al. Photoreceptor cell-derived CAPN5 regulates retinal pigment epithelium cell proliferation through direct regulation of SLIT2 cleavage. Invest Ophthalmol Vis Sci. 2018;59(5):1810–1821. doi:10.1167/iovs.17-22689.
  • Boyce TM, Whitmore SS, Varzavand K, et al. Long-term outcomes and risk factors for severe vision loss in Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV). Am J Ophthalmol. 2022;233:144–152. doi:10.1016/j.ajo.2021.07.015.
  • Tlucek PS, Folk JC, Sobol WM, Mahajan VB. Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy. Clin Ophthalmol. 2013;7:1093–1098.
  • Velez G, Bassuk AG, Colgan D, Tsang SH, Mahajan VB. Therapeutic drug repositioning using personalized proteomics of liquid biopsies. JCI Insight. 2017;2(24):e97818. doi:10.1172/jci.insight.97818.
  • Starr MR, Smith WM. Histoplasmosis following systemic immunomodulatory therapy for ocular inflammation. Am J Ophthalmol. 2019;198:88–96. doi:10.1016/j.ajo.2018.09.033.
  • Little JA, Sen ES, Strike H, et al. The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhood. J Rheumatol. 2014;41(1):136–139. doi:10.3899/jrheum.130594.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.